Can Quantitative Measures of T790M Allelic Fraction Predict Survival Outcomes in Patients Receiving Osimertinib? Observations From an Early Access Programme
| Autor: | Chan, O.S.H. ∗, †, Lee, V.H.F. ‡, Nyaw, S.F. §, Kam, M.T.Y. †, Lee, K.W.C. ||, Lam, K.C. ¶ |
|---|---|
| Zdroj: | In Clinical Oncology July 2021 33(7):e305-e314 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect